We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Panel Calls for U.S. FDA Reclassification of TB Devices
Advisory Panel Calls for U.S. FDA Reclassification of TB Devices
August 2, 2011
The FDA’s Microbiology Devices advisory panel has unanimously recommended the U.S. Food and Drug Administration (FDA) consider down-classifying certain diagnostic tests for tuberculosis (TB) infections.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor